一项随机临床研究,评估沙他卡罗治疗2型糖尿病的效果

Gargee Rb, G. Gopalakrishna, Sowmyashree Up
{"title":"一项随机临床研究,评估沙他卡罗治疗2型糖尿病的效果","authors":"Gargee Rb, G. Gopalakrishna, Sowmyashree Up","doi":"10.21760/jaims.5.2.5","DOIUrl":null,"url":null,"abstract":"Background: Non-communicable diseases are posing major health and development threats. The Worldwide, approximately 200 million people currently have type 2 DM, a prevalence that has been predicted to increase to 366 million by 2030. Diabetes Mellitus comprises a group of common metabolic disorders that share the phenotype of hyperglycemia, with an increase incidence worldwide. The Indian subcontinent has a higher prevalence of DM than any other region in the world, and two to three times the reported prevalence in western countries. Recent surveys say that diabetes is affecting 10-16% of urban population. The disease Madhumeha described in Ayurveda bears close resemblance to Diabetes Mellitus. Objectives: To evaluate the effect of Saptachakra Choorna in the management of Madhumeha w.s.r. to type 2 DM and to compare it with drug taken in the control group. Materials and Method: In the present study, two groups were taken each comprising of 20 patients who fulfilled the diagnostic and inclusion criteria. Subjects of group A were administered Saptachakra Choorna 6gms twice daily and subjects of group B were administered tablet Metformin 500 mg one tablet twice daily, both before food and for a period of 45 days. Observation and Results: In the present study, majority of the symptoms showed clinically significant improvement by Saptachakra Choorna and metformin 500 mg, however it was not statistically significant. In the glycemic parameters like FBS, PPBS, FUS and PPUS within the group administered Saptachakra Choorna 6 gms only FBS and PPBS showed significant improvement where as parameters like FUS and PPUS there was no much improvement and within the group administered tablet Metformin 500 mg significant improvement in all the parameters were observed. On comparing the results between the two groups, the group administered tablet Metformin 500 mg showed a better result than the group administered Saptachakra Choorna. Conclusion: By seeing overall improvement and applying Chi Square Test, tablet Metformin 500 mg showed a better result than Saptachakra Choorna.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A randomized clinical study to evaluate the effect of Saptachakra in management of Madhumeha w.s.r. to type 2 diabetes mellitus\",\"authors\":\"Gargee Rb, G. Gopalakrishna, Sowmyashree Up\",\"doi\":\"10.21760/jaims.5.2.5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Non-communicable diseases are posing major health and development threats. The Worldwide, approximately 200 million people currently have type 2 DM, a prevalence that has been predicted to increase to 366 million by 2030. Diabetes Mellitus comprises a group of common metabolic disorders that share the phenotype of hyperglycemia, with an increase incidence worldwide. The Indian subcontinent has a higher prevalence of DM than any other region in the world, and two to three times the reported prevalence in western countries. Recent surveys say that diabetes is affecting 10-16% of urban population. The disease Madhumeha described in Ayurveda bears close resemblance to Diabetes Mellitus. Objectives: To evaluate the effect of Saptachakra Choorna in the management of Madhumeha w.s.r. to type 2 DM and to compare it with drug taken in the control group. Materials and Method: In the present study, two groups were taken each comprising of 20 patients who fulfilled the diagnostic and inclusion criteria. Subjects of group A were administered Saptachakra Choorna 6gms twice daily and subjects of group B were administered tablet Metformin 500 mg one tablet twice daily, both before food and for a period of 45 days. Observation and Results: In the present study, majority of the symptoms showed clinically significant improvement by Saptachakra Choorna and metformin 500 mg, however it was not statistically significant. In the glycemic parameters like FBS, PPBS, FUS and PPUS within the group administered Saptachakra Choorna 6 gms only FBS and PPBS showed significant improvement where as parameters like FUS and PPUS there was no much improvement and within the group administered tablet Metformin 500 mg significant improvement in all the parameters were observed. On comparing the results between the two groups, the group administered tablet Metformin 500 mg showed a better result than the group administered Saptachakra Choorna. Conclusion: By seeing overall improvement and applying Chi Square Test, tablet Metformin 500 mg showed a better result than Saptachakra Choorna.\",\"PeriodicalId\":153289,\"journal\":{\"name\":\"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21760/jaims.5.2.5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21760/jaims.5.2.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:非传染性疾病正在对健康和发展构成重大威胁。目前全世界约有2亿人患有2型糖尿病,预计到2030年患病率将增加到3.66亿。糖尿病包括一组常见的代谢紊乱,具有高血糖的表型,在世界范围内发病率不断增加。印度次大陆的糖尿病患病率高于世界上任何其他地区,是西方国家报告患病率的两到三倍。最近的调查显示,糖尿病正在影响10-16%的城市人口。Madhumeha在阿育吠陀中描述的疾病与糖尿病非常相似。目的:评价三叶散对2型糖尿病的治疗效果,并与对照组进行比较。材料与方法:本研究分为两组,每组20例符合诊断和纳入标准的患者。A组患者给予七叶参6g,每日2次;B组患者给予二甲双胍片剂500 mg, 1片,每日2次,均在餐前服用,疗程45 d。观察与结果:本研究中,小檗加二甲双胍500 mg治疗后,多数症状均有临床显著改善,但无统计学意义。在血糖指标如FBS、PPBS、FUS和PPUS中,给药6克的组只有FBS和PPBS有明显改善,而FUS和PPUS没有明显改善,给药500毫克的二甲双胍组所有指标均有显著改善。比较两组疗效,二甲双胍片剂500 mg组疗效优于七叶草组。结论:二甲双胍片剂500 mg的疗效优于七爪草片。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A randomized clinical study to evaluate the effect of Saptachakra in management of Madhumeha w.s.r. to type 2 diabetes mellitus
Background: Non-communicable diseases are posing major health and development threats. The Worldwide, approximately 200 million people currently have type 2 DM, a prevalence that has been predicted to increase to 366 million by 2030. Diabetes Mellitus comprises a group of common metabolic disorders that share the phenotype of hyperglycemia, with an increase incidence worldwide. The Indian subcontinent has a higher prevalence of DM than any other region in the world, and two to three times the reported prevalence in western countries. Recent surveys say that diabetes is affecting 10-16% of urban population. The disease Madhumeha described in Ayurveda bears close resemblance to Diabetes Mellitus. Objectives: To evaluate the effect of Saptachakra Choorna in the management of Madhumeha w.s.r. to type 2 DM and to compare it with drug taken in the control group. Materials and Method: In the present study, two groups were taken each comprising of 20 patients who fulfilled the diagnostic and inclusion criteria. Subjects of group A were administered Saptachakra Choorna 6gms twice daily and subjects of group B were administered tablet Metformin 500 mg one tablet twice daily, both before food and for a period of 45 days. Observation and Results: In the present study, majority of the symptoms showed clinically significant improvement by Saptachakra Choorna and metformin 500 mg, however it was not statistically significant. In the glycemic parameters like FBS, PPBS, FUS and PPUS within the group administered Saptachakra Choorna 6 gms only FBS and PPBS showed significant improvement where as parameters like FUS and PPUS there was no much improvement and within the group administered tablet Metformin 500 mg significant improvement in all the parameters were observed. On comparing the results between the two groups, the group administered tablet Metformin 500 mg showed a better result than the group administered Saptachakra Choorna. Conclusion: By seeing overall improvement and applying Chi Square Test, tablet Metformin 500 mg showed a better result than Saptachakra Choorna.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Quality standards of Palasha Kshara Gritha with reference to different vessels Pharmaceutico-analytical study of Mayurpiccha Bhasma - An Ayurvedic preparation Clinical evaluation of Amrita Ghrita Sneha-Pana followed by Pippalyadi Yoga Virechana in the management of Vicharchika (chronic dermatitis) A Biochemical Approach to Understand the Concept of Snigdha Guna of Ghee and Ruksha Guna of Terminalia arjuna on Behaviour of 3T3-L1 Cell Line with Respect to Adipocytic and Anti-Adipocytic Activity : In Vitro Clinal study of Pippalyadya Lau in the management of Tamaka Shwasa
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1